Type 2 Diabetes (T2D) Clinical Trials

Find Type 2 Diabetes (T2D) Clinical Trials Near You

Exercise Impact on Dietary Protein Efficiency in Older Adults With Type 2 Diabetes

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In this randomized controlled trial, 30 older adults (aged\> 65 years; 15 with T2D, 15 controls) will participate in a 12-week progressive exercise training program. They will undergo pre- and post-testing that includes body composition measures; oral glucose tolerance testing; cardiovascular fitness and muscle performance testing; dietary protein efficiency assessed using the indicator amino acid oxidation (IAAO) method; and a gut microbiota trial. The dietary protein efficiency trial will include repeated ingestion of crystallized amino acids (drink) containing stable isotopes, urine samples, and breath samples. The gut microbiome trial will consist of a single ingestion of a Mediterranean-based modeled meal enriched with 13C-phenylalanine (in the drink) and repeated blood draws. Participants will also be asked to give a fecal sample after the gut microbiome trial.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: t
View:

⁃ At least 65 years old

⁃ Body mass index: 25-40 kg/m\^2

⁃ Female: Waist to hip ratio \>0.8

⁃ Male: Waist to hip ratio \>1.0

⁃ Free from structured exercise during the prior 6 months (mo) weight stable for the prior 6 months

‣ T2D group:

• Diagnosed by a physician with elevated glycosylated hemoglobin (HbA1c) \>6.5%

‣ Control group:

• Normoglycemic with HbA1c levels not exceeding 5.6% and fasting blood glucose levels below or equal to 99 mg/dL (5.5mmol)

Locations
United States
Illinois
Freer Hall - University of Illinois
RECRUITING
Urbana
Contact Information
Primary
Nicholas Burd (Professor), PhD
naburd@illinois.edu
2172440970
Backup
Gena Irwin (Research Assistant), M.S
genai2@illinois.edu
3608883281
Time Frame
Start Date: 2026-03-15
Estimated Completion Date: 2028-07-01
Participants
Target number of participants: 30
Treatments
Active_comparator: Non-Diabetic
Non-diabetic control group. Will be assigned to all pre-/post-testing and complete the 12-week intervention period.
Experimental: Diabetic group
Diagnosed diabetic group. Will complete all pre- and post-testing and the 12-week intervention period.
Related Therapeutic Areas
Sponsors
Collaborators: American Diabetes Association
Leads: University of Illinois at Urbana-Champaign

This content was sourced from clinicaltrials.gov